KEI statement on license agreement between the NIH and the WHO Covid-19 Technology Access Pool (C-TAP): keionline.org/37782

The President of the United States just announced an agreement with the WHO C-TAP for vaccine, therapeutic and diagnostic technologies!

Join #WorldHealthAssembly side event on lessons learnt from #Covid19 Technology Access Pool #CTAP .

How can this mechanism for sharing IP & know-how for global access to key medical products be more effective?

📅 18 May, 3PM CEST
✍️ Register & more info: us06web.zoom.us/webinar/regist…

Moderna Claims Compulsory License from U.S. Government to Use Third Party Patents in its Covid-19 Vaccine

keionline.org/37751

This new TRIPS text from the WTO, it's generally the same as the earlier leaked text, but now with two brackets, one on the definition of eligible countries and the second one regarding requirement to list each patent in non-voluntary authorization.

At a Ways and Means Hearing, Rep. Lloyd Doggett makes these comments to HHS Secretary Becerra, including a comment on the Xtandi march-in petition.

youtube.com/watch?v=tMMB3d…

USTR's 2022 Special 301 list is out.

ustr.gov/sites/default/…

Now vaccine companies should follow suit and share their manufacturing know how with World Health Organization (WHO) #ctap and the MedicinesPatentPool without delay. The People's Vaccine

Secretary Xavier Becerra World Health Organization (WHO) MedicinesPatentPool 'WHO, dozens of foreign countries and public health advocates have spent nearly two years urging the United States and other wealthy nations to share the technologies linked with their coronavirus vaccines, diagnostics and therapeutics.' #CTAP KEI Wemos Medicines Law&Policy

U.S. to share some coronavirus technologies with World Health Organization washingtonpost.com/health/2022/03… Secretary Xavier Becerra World Health Organization (WHO) #CTAP MedicinesPatentPool

Senators Warren and King, and Representative Doggett ask HHS Secretary Becerra to move forward on Xtandi march in and government use rights, under existing Bayh-Dole safeguards

keionline.org/37402

Xtandi Bayh-Dole rights case: Memorandum in Support of Prostate Cancer Patient Petition Asking HHS to Use the US Government’s Rights in Patents to Enable Generic Competition

keionline.org/37252

English version of press release on compulsory license request in Chile for Pfizer's Paxlovid by @innovarteorg

Compulsory license request in Chile for Pfizer's Paxlovid by @innovarteorg

STAT oped by Peter Arno, Robert Sachs and Kathryn Ardizzone: Will the Biden administration use ‘march-in’ to protect prostate cancer patients from excessive drug prices.

statnews.com/2022/01/03/mar… via STAT

Research by Luis Gil Abinader on the 'International landscape of molnupiravir patents'

keionline.org/36779

$10 billion US-Pfizer COVID-19 Contract Has Provision That Allows Pfizer to Charge More in the Future

keionline.org/36547

Biden Administration’s $3.5 Billion Purchase Agreement with Pfizer for International Vaccine Donation keionline.org/36568 Kathryn Ardizzone KEI KEI

Biden Administration asked to clarify scope of sanctions exceptions for Cuba’s vaccine program, and to support the evaluation and registration of its COVID-19 vaccines

keionline.org/36381

KEI statement: 23rd meeting of the WHO Expert Committee on the Selection and Use of Essential Medicines keionline.org/36362